DERIVES DE L'ANDROSTENE

European patent · EP0902789 · Deleted

Register entry

Publication number
EP0902789
Application number
EP97921345
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
May 1, 1997
Published
Mar 24, 1999
Granted
Jan 23, 2002
Deleted
May 31, 2009
Reason
Annual fee unpaid
IPC classes
C07J 3/00 (2006.01)
A61K 31/56 (2006.01)
Priority
US 17102 P 09.05.1996
PCT application
PCT/US1997/006812 01.05.1997
PCT publication
WO1997/042214 13.11.1997
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 23, 2009

    Deleted, fee unpaid

    Published in Swissreg on 23.12.2009

  2. Mar 15, 2005

    Transferred

    Owner
    Soft Drugs, Inc., 6219 S.W. 93rd Avenue, Gainesville, FL 32608, USA → IVAX International GmbH, St. Leonhardstrasse 20, Postfach 327, 9001 St. Gallen

    Published in +pat+ No 5 in 2005

  3. Jun 14, 2002

    Agent entered

    Representative
    Kirker & Cie SA, 122, rue de Genève, Case postale 65, 1226 Thônex (Genève)

    Published in PIDTJ No 11 in 2002

  4. Jan 31, 2002

    Granted

    Published in PIDTJ No 2 in 2002

Parties

Inventor

BODOR, Nicholas, S.

Gainesville, FL 32608, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.